241. Peds Rheumatology Flashcards
Difference b/w autoinflammatory and autoimmune disease
autoinflammatory: Innate immunity, neutrophils/macrophaces, tx by blocking cytokine cascade
autoimmune: Adaptive immunity, B/T/Treg cells, tx by blocking lymphocytes/their products
Systemic Juvenile Idiopathic Arthritis
age/sex, dx, pathophysiology
any age, M=F Dx: Polyarticular symmetric arthritis, spiking QUOTIDIAN (1-2x daily) fever for 2 weeks and one more of: evanescent rash (salmon patches/macules with fever), hepatosplenomegaly, lymphadenopathy, serositis) PP: IL-1,6,8 drive inflammation via abnormal cytokine expression (autoINFLAMMATORY), may lead to T cell abnormalities (auto-immune?)
SJIA labs, complication
Lab: anemia, thronbocytosis, high ESR/CRP, High LFTs, Coag changes (high d-dimers, fibrinogen, PT/PTT)
Macrophage Activation Syndrome: severe hyperinflammatory state (cytokine storm) may be FATAL
Labs: DIC (low ESR, pancytopenia), high LFTs, Sky high Ferritin
SJIA tx, prognosis
tx: Glucocorticoids
Biologics (anti-IL-1, anti-IL-6)
2nd line: DMARDS (MTX, leflunomide)
Prognosis: mild-severe involvement, VARIABLE course
Kawasaki Disease
Diagnosis, Epidemiology, Pathogenesis
Dx: FEVER > 5 DAYS plus some change in extremities (edema/red), polymorphous rash, conjunctivitis, lip cracking/strawberry tongue, cervical lymphadenopathy
E: highest in japan/asain americans, <5 y/o, M>F
P: no evidence, just systemic necrotizing vasculitis with predilection for coronary arteries
KD disease course
Acute febrile phase: 10-14 days after URI/GI sx, fever/cutaneous sx, carditis/pericarditis/abd pain/irritability
Subacute phase (2-4 weeks): desquamation, arthritis (self-limiting), aneurysms due to vessel inflammation
Convalescent phase (months): asx but aneurysms may grow
KD therapy and prognosis
TX: high does ASA/IVIG in first 10 days to decrease coronary involvement
IVIG KEY
Steroids/biologics if refractory to IVIG
Prognosis: 5% develop aneurysms, leading cause of CAD in children, early MI in young adults
IgA Vasculitis
Epidemiology, Pathogenesis
E: most common child vasculitis, 3-15y/o, M>F, more in winter months
P: infectious trigger (Group A Strep), IgA-mediated dysregulated immune response to antigen, alternate complement tirggered, some HLA predisposition if genetic
Clinical signs of IgAV
Palpable purpura - gravity-dependent
GI: Currant jelly stools, colicky abd pain (intermittent intense pain) - risk of intussusception - telescoping of small bowel
Arthralgia/Arthritis in 50-80% mainly lower extremities
Kidney involvement - hematuria, proteinuria
Subcutaneous periarticular edema
Labs in IgAV
NO THROMBOCYTOPENIA
unremarkable
+IgA wth deposition in mesangial and GI vasculature
UA with high spot creatine and high BP
Tx/Prognosis for IgAV
Tx: Sx - hydration, bland diet, analgesia, anti-inflammatories
Steroids for severe abd pain/arthritis
tx for other complications
Prognosis: recurrence less common/severe, runs course in 4-6 weeks, EXCELLENT prognosis
Juvenile Dermatomyositis
Epidemiology, Dx
73% white, F>M, avg age 6.7years
Dx: RASH + symmetric proximal muscle weakness, high skeletal muscle enzymes in serum, myositis findings in EMG, muscle biopsy/MRI findings
JDM
Etiology, Pathogenesis
E: environment + genetic
environ: UV exposure, maybe infection
genetic: DQAI*0501, TNFa polymorphisms
antibodies specific to myositis
P: Immune complexes activate endothelial cells - damaged by complement activation (due to IC deposition) - release of vWF = occlusion of arterioles and capillaries = infarction of local tissue
JDM Histology
Perifascular Atrophy (small fibrils on edges) Perivascular Infiltrate (lymphocytic)
JDM Clincal Signs
Skin: Rash, sun exposed areas
Gottron’s Papules: over MCP, IP, elbow joints, red pink scaly papules
Heliotrop Rash: periorbital violaceous erythema
Muscle: proximal muscle weakness, Gower’s sign (difficult risking form floow), neck flexion weakness, abdominal weakness